IFP Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.71K Buy
35
+26
+289% +$4.98K ﹤0.01% 3165
2025
Q1
$1.16K Buy
+9
New +$1.16K ﹤0.01% 3303
2024
Q4
Hold
0
4004
2023
Q1
Sell
-30
Closed -$6K 3991
2022
Q4
$6K Sell
30
-23
-43% -$4.6K ﹤0.01% 3703
2022
Q3
$7K Hold
53
﹤0.01% 3863
2022
Q2
$7K Hold
53
﹤0.01% 3607
2022
Q1
$7K Buy
53
+47
+783% +$6.21K ﹤0.01% 3607
2021
Q4
$1K Hold
6
﹤0.01% 2997
2021
Q3
$1K Hold
6
﹤0.01% 2994
2021
Q2
$1K Sell
6
-2
-25% -$333 ﹤0.01% 2881
2021
Q1
$1K Buy
8
+2
+33% +$250 ﹤0.01% 2805
2020
Q4
$0 Sell
6
-50
-89% ﹤0.01% 3561
2020
Q3
$3K Hold
56
﹤0.01% 2351
2020
Q2
$4K Sell
56
-151
-73% -$10.8K ﹤0.01% 2161
2020
Q1
$10K Sell
207
-38
-16% -$1.84K ﹤0.01% 1760
2019
Q4
$16K Sell
245
-250
-51% -$16.3K ﹤0.01% 1720
2019
Q3
$29K Buy
+495
New +$29K ﹤0.01% 1602
2019
Q1
Sell
-103
Closed -$9K 2925
2018
Q4
$9K Buy
103
+21
+26% +$1.84K ﹤0.01% 2520
2018
Q3
$14K Sell
82
-14
-15% -$2.39K ﹤0.01% 2627
2018
Q2
$12K Sell
96
-37
-28% -$4.63K ﹤0.01% 2743
2018
Q1
$11K Hold
133
﹤0.01% 2732
2017
Q4
$11K Sell
133
-239
-64% -$19.8K ﹤0.01% 2728
2017
Q3
$32K Sell
372
-18
-5% -$1.55K ﹤0.01% 2270
2017
Q2
$30K Sell
390
-165
-30% -$12.7K ﹤0.01% 2297
2017
Q1
$37K Buy
555
+422
+317% +$28.1K ﹤0.01% 2089
2016
Q4
$8K Sell
133
-32
-19% -$1.93K ﹤0.01% 3016
2016
Q3
$11K Sell
165
-45
-21% -$3K ﹤0.01% 2755
2016
Q2
$16K Buy
+210
New +$16K ﹤0.01% 2477
2016
Q1
Sell
-200
Closed -$14K 2948
2015
Q4
$14K Buy
+200
New +$14K ﹤0.01% 2371